Do young adults know enough about HPV? new survey reveals gaps
NCT ID NCT07418203
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study surveyed 29 people aged 18-19 in France to find out what they know about human papillomavirus (HPV) and the HPV vaccine. The goal was to identify gaps in knowledge that could be addressed through better education. The results may help improve vaccination rates and informed decision-making.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could highlight where education about HPV and its vaccine is lacking, helping to design better awareness campaigns.
- What could go wrong
- This is a small, completed survey of only 29 people in France, so the findings may not apply to other groups or countries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ufr Medecine Urca
Reims, 51100, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a cream after surgery stop cervical cancer in HIV-Positive women?
- Could a malaria drug help fight HPV in women with HIV?
- Can a probiotic gel help women clear HPV and early cervical lesions?
- New HPV test aims to bring screening to more people
- Could 2 HPV vaccine doses be enough for women 27-45? new trial aims to find out.
- Scientists hunt for genetic clues to severe HPV infections